 |
ombitasvir/paritaprevir/ritonavir and dasabuvir |
|---|---|
| Trade Name | Viekira Pak |
| Orphan Indication | Pediatric patients with hepatitis C virus infection (0 through 16 years of age) |
| USA Market Approval | USA |
| USA Designation Date | 2015-07-16 00:00:00 |
| Sponsor | Abbvie, Inc.;1 North Waukegan Road;North Chicago, Illinois, 60064 |
